Global Excoriation (Skin-picking) Disorder Market – Industry Trends and Forecast to 2030

Request for TOC طلب جدول المحتويات Speak to Analyst تحدث إلى المحلل Buy Now اشتري الآن Inquire Before Buying استفسر قبل Free Sample Report تقرير عينة مجاني

Global Excoriation (Skin-picking) Disorder Market – Industry Trends and Forecast to 2030

  • Pharmaceutical
  • Upcoming Report
  • Oct 2023
  • Global
  • 350 الصفحات
  • عدد الجداول: 220
  • عدد الأرقام: 60

Global Excoriation Skin Picking Disorder Market

حجم السوق بالمليار دولار أمريكي

CAGR :  % Diagram

Diagram فترة التنبؤ
2023 –2030
Diagram حجم السوق (السنة الأساسية)
USD 657.58 Million
Diagram حجم السوق (سنة التنبؤ)
USD 1,027.25 Million
Diagram CAGR
%
Diagram اللاعبين الرئيسيين في الأسواق
  • GlaxoSmithKline
  • Pfizer
  • AstraZeneca
  • Johnson & Johnson
  • Bristol Myers Squibb

Global Excoriation (Skin-picking) Disorder Market, By Treatment (Antidepressants, Anticonvulsants, Antipsychotics, Cognitive-behavioural Therapy (CBT), Others), Diagnosis (Physical Examination, Others), Dosage (Tablet, Injection, Others), Route of Administration (Oral, Intravenous, Others), End-Users (Clinic, Hospital, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) – Industry Trends and Forecast to 2030.

Excoriation (Skin-picking) Disorder Market

Excoriation (Skin-picking) Disorder Market Analysis and Size

Excoriation disorder is an obsessive-compulsive disorder-like mental disease. It is defined as picking at one's own skin over and over again, resulting in skin sores and causing severe disruption in one's life. Picking at healthy skin, small skin abnormalities, lesions, or scabs is a common occurrence. This is a chronic condition, with periods of remission interspersed with times of increased symptom intensity. This neurological disorder can produce severe distress and impairment in various areas of functioning, including social avoidance. Excoriation disorder is also called chronic skin-picking or dermatillomania.

The rise in excoriation (skin-picking) disorder and rising healthcare expenditure are the major factors influencing the market growth rate. Furthermore, advancements in medical technology, growing government funding, and rising initiatives by public and private organizations to spread awareness about the disease and its available treatment options are the factors that will expand the excoriation (skin-picking) disorder market. Likewise, growing incidences of stress, depression, and anxiety, changing lifestyles, and the dearth of physical exercise will cushion the market growth rate.

Data Bridge Market Research analyses that the global excoriation (skin-picking) disorder market which was USD 657.58 million in 2022, would rocket up to USD 1,027.25 million by 2030, and is expected to undergo a CAGR of 5.8% during the forecast period. “Physical examination” dominates the diagnosis segment of the global excoriation (skin-picking) disorder market owing to rise in the aging population. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Excoriation (Skin-picking) Disorder Market Scope and Segmentation

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015-2020)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Treatment (Antidepressants, Anticonvulsants, Antipsychotics, Cognitive-behavioral Therapy (CBT), Others), Diagnosis (Physical Examination, Others), Dosage (Tablet, Injection, Others), Route of Administration (Oral, Intravenous, Others), End-Users (Clinic, Hospital, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy)

Countries Covered

U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E., Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa

Market Players Covered

GlaxoSmithKline plc (U.K.), Pfizer Inc. (U.S.), AstraZeneca (U.S.), Johnson & Johnson Private Limited (U.S.), Bristol-Myers Squibb Company (U.S.), Sandoz International GmbH (Germany), Apotex Inc. (Canada), Mylan N.V. (Netherlands), H. Lundbeck A/S (Denmark), Allergan (Ireland), Sanofi (France), Merck Sharp & Dohme Corp. (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Alkermes (Ireland), Takeda Pharmaceutical Company Limited (Japan), OPKO Health, Inc. (U.S.), Intra-Cellular Therapies Inc. (U.S.), Janssen Pharmaceuticals, Inc. (U.S.), Lupin (India), Novartis AG (Switzerland), Bausch Health Companies Inc. (Canada), Eli Lilly and Company (U.S.), Sumitomo Dainippon Pharma Co., Ltd. (Japan), AbbVie Inc. (U.S.), and Dr. Reddy’s Laboratories Ltd. (India)

Market Opportunities

  • Rise in the research and development activities
  • Rising aging population

Market Definition

Excoriation disorder is an obsessive-compulsive disorder such as mental disease. It is defined by picking at one's own skin over and over again, resulting in skin sores and causing severe disruption in one's life. Picking at healthy skin, small skin abnormalities, lesions, or scabs is a common occurrence. This is a chronic condition, with periods of remission interspersed with times of increased symptom intensity. This neurological disorder can produce severe distress and impairment in various areas of functioning, including social avoidance. Excoriation disorder is also called chronic skin-picking or dermatillomania.

Global Excoriation (Skin-picking) Disorder Market Dynamics

Drivers

  • Growing Awareness and Diagnosis

Increased awareness of mental health issues, including Excoriation Disorder, has led to more individuals seeking help and receiving a formal diagnosis. Greater recognition of the disorder has expanded the potential market for treatments and services.

  • Psychological and Behavioral Therapies

Cognitive-Behavioral Therapy (CBT) and related therapies have shown promise in treating excoriation disorder. The availability and accessibility of these evidence-based therapies contribute to market growth.

Opportunities

  • Telehealth and Digital Therapeutics

The rise of telehealth and digital therapeutic solutions in mental healthcare presents opportunities for reaching individuals with excoriation disorder, especially those who may have limited access to in-person treatment. Virtual therapy and digital interventions can provide support and treatment options.

Restraint/Challenge

  • Limited Treatment Options

While therapies such as CBT have shown promise, there is still a lack of specific pharmacological treatments approved for Excoriation Disorder. This limits the range of treatment options available.

This global excoriation (skin-picking) disorder market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global excoriation (skin-picking) disorder market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Excoriation (Skin-Picking) Disorder Market Scope

Global excoriation (skin-picking) disorder market is categorized into six notable segments which are based on the treatment, diagnosis, dosage, route of administration, end-users, and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Treatment

  • Antidepressants
  • Anticonvulsants
  • Antipsychotics
  • Cognitive-Behavioral Therapy (cbt)
  • Others

Diagnosis

  • Physical Examination
  • Others

Dosage

  • Tablet
  • Injection
  • Others

Route of Administration

  • Oral
  • Intravenous
  • Others

End-Users

  • Clinic
  • Hospital
  • Others

Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

Global Excoriation (Skin-Picking) Disorder Market Regional Analysis/Insights

Global excoriation (skin-picking) disorder market is analyzed and market size information is provided by the treatment, diagnosis, dosage, route of administration, end-users and distribution channel as referenced above.

The countries covered in the excoriation (skin-picking) disorder market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E., Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.

North America dominates the excoriation (skin-picking) disorder market due to major key players, high healthcare expenditure and well-developed healthcare infrastructure in this region.

Asia-Pacific is expected to grow during the forecast period of 2023 to 2030 due to the increasing research and development activities, rising investment in the healthcare sector and growing government support in this region.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Competitive Landscape and Global Excoriation (Skin-Picking) Disorder Market Share Analysis

Excoriation (skin-picking) disorder market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to excoriation (skin-picking) disorder market research.

Some of the major players operating in the global excoriation (skin-picking) disorder market are:

  • GlaxoSmithKline plc (U.K.)
  • Pfizer Inc. (U.S.)
  • AstraZeneca (U.S.)
  • Johnson & Johnson Private Limited (U.S.)
  • Bristol-Myers Squibb Company (U.S.)
  • Sandoz International GmbH (Germany)
  • Apotex Inc. (Canada)
  • Mylan N.V. (U.S.)
  • H. Lundbeck A/S (Denmark)
  • Allergan (Ireland)
  • Sanofi (France)
  • Merck Sharp & Dohme Corp. (U.S.)
  • Teva Pharmaceutical Industries Ltd. (Israel)
  • Alkermes (Ireland)
  • Takeda Pharmaceutical Company Limited (Japan)
  • OPKO Health, Inc. (U.S.)
  • Intra-Cellular Therapies Inc. (U.S.)
  • Janssen Pharmaceuticals, Inc. (U.S.)
  • Lupin (India)
  • Novartis AG (Switzerland)
  • Bausch Health Companies Inc. (Canada)
  • Eli Lilly and Company (U.S.)
  • Sumitomo Dainippon Pharma Co., Ltd. (Japan)
  • AbbVie Inc. (U.S.)
  • Dr. Reddy’s Laboratories Ltd. (India)


SKU-

احصل على إمكانية الوصول عبر الإنترنت إلى التقرير الخاص بأول سحابة استخبارات سوقية في العالم

  • لوحة معلومات تحليل البيانات التفاعلية
  • لوحة معلومات تحليل الشركة للفرص ذات إمكانات النمو العالية
  • إمكانية وصول محلل الأبحاث للتخصيص والاستعلامات
  • تحليل المنافسين باستخدام لوحة معلومات تفاعلية
  • آخر الأخبار والتحديثات وتحليل الاتجاهات
  • استغل قوة تحليل المعايير لتتبع المنافسين بشكل شامل
طلب التجريبي

منهجية البحث

يتم جمع البيانات وتحليل سنة الأساس باستخدام وحدات جمع البيانات ذات أحجام العينات الكبيرة. تتضمن المرحلة الحصول على معلومات السوق أو البيانات ذات الصلة من خلال مصادر واستراتيجيات مختلفة. تتضمن فحص وتخطيط جميع البيانات المكتسبة من الماضي مسبقًا. كما تتضمن فحص التناقضات في المعلومات التي شوهدت عبر مصادر المعلومات المختلفة. يتم تحليل بيانات السوق وتقديرها باستخدام نماذج إحصائية ومتماسكة للسوق. كما أن تحليل حصة السوق وتحليل الاتجاهات الرئيسية هي عوامل النجاح الرئيسية في تقرير السوق. لمعرفة المزيد، يرجى طلب مكالمة محلل أو إرسال استفسارك.

منهجية البحث الرئيسية التي يستخدمها فريق بحث DBMR هي التثليث البيانات والتي تتضمن استخراج البيانات وتحليل تأثير متغيرات البيانات على السوق والتحقق الأولي (من قبل خبراء الصناعة). تتضمن نماذج البيانات شبكة تحديد موقف البائعين، وتحليل خط زمني للسوق، ونظرة عامة على السوق ودليل، وشبكة تحديد موقف الشركة، وتحليل براءات الاختراع، وتحليل التسعير، وتحليل حصة الشركة في السوق، ومعايير القياس، وتحليل حصة البائعين على المستوى العالمي مقابل الإقليمي. لمعرفة المزيد عن منهجية البحث، أرسل استفسارًا للتحدث إلى خبراء الصناعة لدينا.

التخصيص متاح

تعد Data Bridge Market Research رائدة في مجال البحوث التكوينية المتقدمة. ونحن نفخر بخدمة عملائنا الحاليين والجدد بالبيانات والتحليلات التي تتطابق مع هدفهم. ويمكن تخصيص التقرير ليشمل تحليل اتجاه الأسعار للعلامات التجارية المستهدفة وفهم السوق في بلدان إضافية (اطلب قائمة البلدان)، وبيانات نتائج التجارب السريرية، ومراجعة الأدبيات، وتحليل السوق المجدد وقاعدة المنتج. ويمكن تحليل تحليل السوق للمنافسين المستهدفين من التحليل القائم على التكنولوجيا إلى استراتيجيات محفظة السوق. ويمكننا إضافة عدد كبير من المنافسين الذين تحتاج إلى بيانات عنهم بالتنسيق وأسلوب البيانات الذي تبحث عنه. ويمكن لفريق المحللين لدينا أيضًا تزويدك بالبيانات في ملفات Excel الخام أو جداول البيانات المحورية (كتاب الحقائق) أو مساعدتك في إنشاء عروض تقديمية من مجموعات البيانات المتوفرة في التقرير.

Frequently Asked Questions

The market is segmented based on Global Excoriation (Skin-picking) Disorder Market, By Treatment (Antidepressants, Anticonvulsants, Antipsychotics, Cognitive-behavioural Therapy (CBT), Others), Diagnosis (Physical Examination, Others), Dosage (Tablet, Injection, Others), Route of Administration (Oral, Intravenous, Others), End-Users (Clinic, Hospital, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) – Industry Trends and Forecast to 2030. .
The Global Excoriation Skin Picking Disorder Market size was valued at USD 657.58 USD Million in 2022.
The Global Excoriation Skin Picking Disorder Market is projected to grow at a CAGR of 5.8% during the forecast period of 2023 to 2030.
The major players operating in the market include GlaxoSmithKline, Pfizer, AstraZeneca, Johnson & Johnson, Bristol Myers Squibb, Sandoz International, Apotex, Mylan, H. Lundbeck, Allergan, Sanofi, Merck Sharp & Dohme, Teva Pharmaceutical Industries, Alkermes, Takeda Pharmaceutical Company, OPKO Health, Intra Cellular Therapies, Janssen Pharmaceuticals, Lupin, Novartis, Bausch Health Companies, Eli Lilly and Company, Sumitomo Dainippon Pharma, AbbVie, Dr. Reddy's Laboratories.
The market report covers data from the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E., Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.